Charles Nemeroff
Professor and Chair of the Department of Psychiatry and Behavioral Sciences at Dell Medical School, The University of Texas at Austin
Data updated
Research Footprint
Charles Nemeroff appears in 5 tracked papers (2015–2023), most studied alongside Ketamine, Psilocybin and Esketamine, across Depressive Disorders, Major Depressive Disorder (MDD) and Treatment-Resistant Depression (TRD).
Most-cited paper: Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation (676 citations).
Frequent co-authors: Gerard Sanacora, Sanjay Mathew and Mark Andrew Frye.
Background & Research
Charles Barnet Nemeroff is an American psychiatrist and neuropsychopharmacology researcher. He earned his medical and doctoral degrees from the University of North Carolina School of Medicine, trained in psychiatry at UNC and Duke, and previously held senior academic leadership roles at Emory University and the University of Miami before joining the University of Texas at Austin.
Key Impact
Charles B. Nemeroff is a highly cited psychiatrist whose work has helped shape modern research and expert opinion on ketamine, esketamine, and emerging psychedelic treatments for mood disorders.
Collaboration Network
20 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Top Collaborators
Affiliations
Institutions, companies, and organisations Charles Nemeroff is associated with.
University of Texas at Austin
academicThe Center for Psychedelic Research and Therapy within the Dell Medical School conducts clinical research with various psychedelics, including psilocybin, MDMA, ibogaine, and ayahuasca. A major and unique focus of the center at UTA is its dedication to using psychedelics to treat military veterans suffering from PTSD, as well as adults experiencing prolonged grief disorder and those who have survived childhood trauma.
View stakeholder →Emory University
academicThe Center for Psychedelics and Spirituality at Emory University combines expertise in psychiatry with spiritual health to better understand the therapeutic promise of psychedelics as medicine. Launched at the end of 2022, the group works towards making psychedelic-assisted therapies more effective within a wide cultural and spiritual context.
View stakeholder →University of Miami Miller School of Medicine
The University of Miami Leonard M. Miller School of Medicine is the medical school of the University of Miami in Miami, Florida. It is a research-intensive institution that provides medical education, conducts biomedical research, and delivers clinical care as part of the University of Miami Health system.
View stakeholder →